Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127310571 | 12731057 | 1 | I | 20160831 | 20160912 | 20160912 | EXP | GB-ALVOGEN-2016-ALVOGEN-028388 | ALVOGEN | 73.00 | YR | F | Y | 0.00000 | 20160912 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127310571 | 12731057 | 1 | PS | ATENOLOL. | ATENOLOL | 1 | Oral | 1 DF QD | Y | BPQ084040 | 18240 | 50 | MG | TABLET | |||||
| 127310571 | 12731057 | 2 | SS | INDAPAMIDE. | INDAPAMIDE | 1 | Oral | Y | 0 | TABLET | |||||||||
| 127310571 | 12731057 | 3 | C | ALENDRONIC ACID | ALENDRONIC ACID | 1 | Unknown | U | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127310571 | 12731057 | 1 | Hypertension |
| 127310571 | 12731057 | 2 | Hypertension |
| 127310571 | 12731057 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127310571 | 12731057 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127310571 | 12731057 | Hypersensitivity | |
| 127310571 | 12731057 | Swollen tongue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127310571 | 12731057 | 2 | 201511 | 20160702 | 0 |